Stock EMBI SKYE BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Skye Bioscience, Inc.

Equities

EMBI

US83086J2006

Market Closed - Nasdaq
Other stock markets
 01:30:00 18/06/2024 am IST 		5-day change 1st Jan Change
10.86 USD +3.63% Intraday chart for Skye Bioscience, Inc. +8.82% +299.26%
10/06 Skye Bioscience, Inc. Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program CI
10/06 Skye Bioscience to stop eye disease drug development after failing mid-stage study RE

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Skye Bioscience, Inc. Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program
Skye Bioscience to stop eye disease drug development after failing mid-stage study
Skye Bioscience to discontinue development of eye disease treatment
Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Skye Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Skye Bioscience Announces Board Changes
Skye Bioscience Completes Enrollment of Phase 2A Clinical Trial of SBI-100 Ophthalmic Emulsion in Glaucoma and Ocular Hypertension
Skye Bioscience, Inc. Announces Clinical Development Plan in Obesity for Differentiated Peripheral CB1 Inhibitor, Nimacimab
Skye Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Skye Bioscience, Inc. Announces Board Appointments
Skye Bioscience, Inc. acquired Bird Rock Bio, Inc. for $15.6 million.
Skye Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Skye Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Skye Bioscience, Inc. Auditor Raises 'Going Concern' Doubt
Skye Bioscience, Inc. Announces Board Changes
Skye Bioscience, Inc. Announces Resignation of Bobby Rai as a Member of the Board of Directors and the Nominating and Corporate Governance Committee of the Board
Skye Bioscience, Inc. Appoints Deborah Charych to Board of Directors
Skye Bioscience Announces First-in-Human Phase 1 Trial of Proprietary Cannabinoid Derivative and Nanoemulsion Formulation Designed to Potentially Treat Glaucoma
Skye Bioscience, Inc. Appoints Rai as Member of the Nominating and Corporate Governance Committee of the Board
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EMBI Stock
  4. News Skye Bioscience, Inc.
  5. Other languages